BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER) sold 18.2% of their position (9.94K shares) of MIRUM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $978.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/15/2026ACC: 0001197350-26-000010
Officer· CHIEF FINANCIAL OFFICER
Since Jan 2026
-9.94K
Net shares
Net seller
$978.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
18.33K acquired · 28.28K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+18.33K
Price / share
—
Trade value
—
% of position
50.4%
9/11/2026
36.35K→54.69K
Common Stock
Direct
Shares
−9.94K
Price / share
$98.37
Trade value
$978.09K
% of position
18.2%
9/14/2026
54.69K→44.74K
Total
Net shares
+8.39K
Net value
-$978.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/11/2026 | M · Option Exercise | +18.33K | — | — | 50.4% | 36.35K | 54.69K |
| Common Stock Direct | 9/14/2026 | S · Sale | −9.94K | $98.37 | $978.09K | 18.2% | 54.69K | 44.74K |
| Total | +8.39K | -$978.09K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
18.33K shares
Shares
−18.33K
Strike price
Held after
0.00
Exercisable
—
9/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock18.33K shares | 9/11/2026 | M · Option Exercise | −18.33K | — | 0.00 |